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ABSTACT 
Intraocular lens implantation is becoming an increasingly pop-
ular treatment for cataract patients. Optometrists need to rea-
lize the importance of identifying the perspective IOL patient, be 
knowledgable about the various types of IOL's used, know the 
various complications which may arise due to the surgery itself, 
IOL design, or intolerance of the lens by the patient, and supply 
adequate and professional management in the pre and 
post-operative care of the IOL patient. It is hoped that this paper 
will provide the Optometrist with the necessary information 
required to serve this growing patient population with the 
optimum in professional eye care. 
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INTRODUCTION 
Today's cataract patient has a viable alternative to aphakic glasses and 
contact lenses. Intraocular lenses have become an increasingly popular 
choice of treatment for this population. Improved lens designs and surgical 
techniques have made this a relatively safe procedure with resultant good 
visual functioning. Consequently, Optometrists will be expected to be 
familiar with this procedure, offer this option to their patients, counsil 
their patients about the procedure, refer their patients to a qualified and 
competent Ophthalmologist, and provide appropriate pre and post-operative 
care. This paper will present a brief history of intraocular lenses, their 
current trends of use, the referral and preparation of cataract patients for 
surgery, possible complications stemming from the surgery, and optometric 
management of the IOL patient. 
TYPES of INTRAOCULAR LENSES 
Generally, intraocular lenses (IOL's) can be split into three different 
groups; anterior chamber IOL's (ACIOL's), posterior chamber IOL's (PCIOL's), 
and iris supported lenses. 
ACIOL's are inserted into the anterior chamber and use the angle recess 
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for fixation support. They require a less complicated surgery than the other 
two groups and can be done with either an intracapsular cataract extrac-
tion (ICCE) or an extracapsular cataract extraction (ECCE). Original designs 
were rigid and often touched the cornea causing edema and decomposition. 
They were also hard to measure to accurately fit into the angle causing pain 
if too big or movement of the lens if too small. Introduction of flexible 
lenses and better surgical techniques for measuring the needed size have 
reduced these problems significantly. However, ACIOL's are presently used 
as a secondary implant if there have been problems with the initial surgery. 
PCIOL's have been made possible through improved lens designs and 
surgical techniqes.1 These improvements have made this type of implant the 
lens of choice today. Ideally the lens is placed in the remaining lens capsule 
but often, only the ciliary sulcus is used for support. It is the most refined 
of the IOL surgeries but has many advantages including being closest to the 
natural lens position.2 Other advantages include; the lens is far removed 
from the cornea, the pupil is free to move, there is less chance of the 
surgeon damaging the cornea, and in uncomplicated procedures, there is less 
chance of cystoid macular edema (CME) and retinal detachments occurring. 
Iris supported lenses come in two types. Iris fixated IOL's (IFIOL's), 
which depend on the iris for support and stabilization, and iridocapsular 
IOL's (ICIOL's), which rely on the lens capsule and the iris for support. 
Therefore, the lenses have the advantage of no structures in the angle or 
touching the cornea. Although more complicated surgically, they were met 
with good support initially. Long-term effects, however, showed a higher 
incidence of CME, endothelial cell loss, and iris erosion and atrophy. 
IOL improvements have resulted in a dramatic turnaround in the type of 
IOL's used and the number of implant surgeries. In 1978, approximately 
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154,000 IOL's were implanted. IFIOL's accounted for 52o/o of these, ACIOL's 
25°/o, ICIOL's 19°/o, and PCIOL's 4°/o. In 1983, approximately 550,000eyes 
were implanted. PCIOL's were used in 63°/o of these eyes, ACIOL's in 
36°/o, and IFIOL's and ICIOL's were used in less than 1 o/o.3 Today the trend 
is increasing toward PCIOL's as iris-supported lenses have largely become 
obsolete. The· overall success with these lenses can't compare to the 
results with modern ACIOL's and PCIOL's.4 
REFERRAL and REASSURANCE of a POSSIBLE IOL PATIENT 
The decision to refer a cataract patient for IOL implantation rests with 
the Optometrist. Therefore we, as Optometrists, must be capable of 
balancing the possible benefits of surgery with the possible risks involved. 
We need to decide at which point, if any, during the development of the 
cataract, the benefits of such a surgery would indeed outweigh the risks. A 
referral should not be made until this point is reached, unless an emergency 
case presents itself or if the patient insists upon such a surgery. 
There are many factors to consider; the patients specific visual needs, 
the condition of the fellow eye, and the importance of binocular vision to 
the patient. Unless the surgery will result in vision to perform tasks that 
are important to the patient, he may remain frustrated, no matter how 
successful the surgery. A careful history and discussion with the patient 
will minimize such an outcome. 
The mention of cataract surgery may worry and concern many patients. 
Optometrists must be able and willing to reassure and support these 
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patients. They often have misconceptions about cataract surgery and it is 
our responsibility to explain that even though some problems may have 
existed years ago, many have been solvled today. For instance, patients may 
have the perception that a cataract is a form of cancer, since both grow. 
Another misconception is that a cataracts signal a generalized deterioration 
of the entire body. Some patients may still believe that cataract surgery 
requires prolonged bed rest with head immobilization and many days away 
from work. A discussion with a patient who may have these or similar 
concerns may avoid unwarranted fear and anxiety. We should also explain 
that there is very little pain although some discomfort is present, it is 
usually short lived and can quickly be eliminated. 
Another primary concern of many patients is that of finances. With the 
use of modern techniques and instrumentation, the patient is usually back to 
work very quickly after surgery, thus reducing the high cost of hospitaliza-
tion. Many times the Optometrist may know the patient and his concerns 
much better than the surgeon. A great service to the patient may be 
performed, if along with the referral, a statement is made by the O.D. 
explaining the patient's fianancial situation to the surgeon. In many cases, 
a reduction in fees may be available. 
The patient should also be counciled about the procedure so that they 
know what to expect. If they will be hospitalized, they should be told about 
the various laboratory tests which may be performed, such as blood tests, 
chest X-rays, and EKG's. They should be told to expect a visit from 
various medical specialists such as an anesthesiologist, an intern, or a 
retinal specialist. These studies and consultations are to minimize the 
likelihood of unexpected complications and insure the patients successful 
recovery. A variety of medications will be administered before, during, 
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and after surgery to minimize patient anxiety, pain, and the possibility of 
infection. 
With a proper referral at the right time to a competant surgeon, the risk 
of patient frustration and unhappiness following surgery will be greatly 
reduced. The satisfied patient should return to the referring Optometrist 
within six to seven weeks after surgery for post-operative care, including 
any subsequent correction for residual refractive error.s Today many 
surgical centers return the patient to the Optometrist within two days if 
the surgery is uncomplicated. 
COMPLICATIONS of IOL's 
While IOL surgery is a relatively safe procedure, there are numerous 
long and short term complications that can arise. Recent developments in 
surgery have greatly reduced many of the risks, however it is important that 
we, as Optometrists, recognize what complications may present them-
selves when evaluating an IOL patient, and be able to distinguish between 
those which constitute an emergency from those which do not. 
A) RETINAL COMPLICATIONS 
1) Cystoid Macular Edema (CME) 
CME is a complication of cataract surgery, with or without IOL implan-
tation. It consists of an accumulation of fluid in the cystic spaces of the 
outer plexiform layer causing a thickening of the retina. It is currently 
thought to be caused by one or a combination of the following factors; 
increased permeability of perifoveolar capillaries, ischemic tissue injury, 
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secondary to intraocular inflammation, or traction upon the macula follow-
ing vitreous shifts. Most cases of CME present 4-12 weeks post-
operatively but may occur up to several years later with decreasing acuity 
of 20/50 to 20/200. The patient complains of reduced vision and may be 
photophobic. An exam with a fundus contact lens can show a thickened 
macular area with associated honeycomb appearance but this is often 
difficult to appreciate. Flourescein angiography is the definitive diagnostic 
test for CME. 
Generally, it is more accepted that uncomplicated ECCE produces less 
CME than uncomplicated ICCE. This indicates that the intact posterior cap-
sule may somehow reduce the incidence of CME. Other related factors 
include the patients age, the status of the vascular system, and the overall 
health of the patient. CME is often self limited with resolution approx. 6 
months following onset. 
2) RETINAL DETACHMENT 
It is well established that retinal detachments occur much more fre-
quently in aphakes. One study has shown the risk 65 times higher than that 
among phakic individuals. 6 It is important to note that in recent years, 
there has been a decline in the incidence of retinal detachments pointing to 
better surgical techniques and instrumentation.? 
Detachments are caused by a shifting of the vitreous base during 
surgery. Vitreous loss greatly increases the risk. Some risk factors include 
posterior uveitus, axial myopia, a history of detachment in the oppisite eye, 
and/or a family history of detachment. Onset is usually 6 months 
post-operatively. The patient symptoms may include decreased visual 
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acuity, decreased peripheral or side vision, photophobia, and flashers and 
floaters. 
3) DIFFICULTY in VISUALIZATION of the FUNDUS 
Difficulty in fundus visualization by direct and indirect ophthalmoscopy 
presents another problem, especially with many older IOL styles. This is 
particularly true with some types of iris supported lenses where the pupil 
is often miotic and mydriasis may be difficult to attain. However, with 
modern IOL styles, fundus visualization has become much less of a problem. 
Better mydriasis is now attainable in most instances. Still, peripheral 
fundus visualization through a modern IOL may be difficult due to glare, 
optical abberations, or when a posterior capsular membrane is present. 8 
Visualization of various fundus areas may also be difficult if the IOL is 
tilted, decentered, or subluxated. 
B) IRIS COMPLICATIONS 
1) IRIS CHAFING and EROSION 
The intact surfaces of the iris and ciliary body may be disrupted due to 
excessive contact with any IOL style, thus disrupting the integrity of the 
blood-aqueous barrier. When loops or footplates of an IOL cause iris-ciliary 
touch, the potential increases for a release of substances that may cause 
subsequent inflammation and fibrosis. 
Some consequences of iris erosion and chafing may include late post-
operative hyphema from tearing of iris vessels and pigmentary dispersion 
syndrome. 9 The later may subsequently cause IOL-induced pigmentary 
8 
glaucoma. 
2) IRIDODIALYSIS 
Iridodialysis is a separation of the iris root from its attachment to the 
ciliary body which creates a periperal iris opening. Complications of this 
iris separation are usually minimal, however a large iridodialysis may re-
sult in a severe pupillary displacement or may be a source of intra-
operative or post-operative bleeding.1 0 
3) IRIS PROLAPSE 
Iris prolapse can be caused by severe post-operative trauma. It may be 
recognized by dark uveal material in the wound and by the irregularity of the 
pupil. This prolapse of uveal tissue through a healing cataract incision does 
not seem to be more frequent with an IOL implantation.11 With improved 
implantation techniques, such as improved sutures and consequent tighter 
wound closure, the incidence of post-operative iris prolapse has de-
creased.12 However, if prolapse does occur, prompt surgical closure of the 
wound is required. 
4) IRIDO-PSEUDOPHAKIC SYNECHIAE 
With the use of iris fixated IOL's, posterior synechiae often develop be-
tween the iris and the IOL following ECCE. A permanent iris-IOL synechiae 
can prevent subsequent dilation of the pupil with cycloplegic agents.13 
With time, these iris-IOL adhesions may vascularize. In many cases, rapid 
mydriasis or miosis may cause these vessels to rupture, with consequent 
hemorrhage and uveitis.14 
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While the incidence of the irido-pseudophakic synechiae is fairly high 
with iris-fixated IOL's, it's occurrence is much less with the use of anterior 
and posterior implants. 
5) PUPILLARY BLOCK 
Pupillary block is a closure of the pupil which may prevent the flow of 
aqueous from the posterior to the anterior chamber, and is a well known 
complication of cataract surgery and IOL implantation.15 Possible causes 
include leakage of a wound, inflammation, hemorrhage, and/or vitreous 
prolapse. It may lead to glaucoma, especially if associated with iris fixated 
or anterior chamber lenses. This type of glaucoma rarely occurs with 
posterior chamber IOL's. Since pupillary block is very common with 
iris-supported lenses, it is essential that peripheral iridectomies be 
performed to ensure continued circulation of aqueous humor from the 
posterior chamber to the anterior chamber. 
6) PERIPHERAL ANTERIOR SYNECHIAE 
Peripheral anterior synechiae (PAS} formation may occur following 
implantation of anterior chamber IOL's.16, 17 These synechia, which attach 
to anterior chamber loops or footplates within the angle recess, are usually 
innocuous if the IOL is properly sized and may even be useful in improving 
fixation of the lens. However, if these synechiae occur in abundance and are 
broadly scattered throughout the angle, a potential may exist for secondary 
glaucoma. 
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7) PUPILLARY CAPTURE 
Pupillary capture is a result of the prolapse of a posterior chamber IOL. 
18,19 This is frequently secondary to post-operative dilation to reduce 
posterior synechiae, and may result in an elliptical shaped pupil and visual 
distortion. 20 Other than the possible complication of visual distortion, 
pupillary capture usually does not create a serious problem. 
8) IRIS TUCK 
Iris tuck is a condition in which a segment or fold of peripheral iris 
tissue is entrapped in the angle of an anterior chamber IOL. This can cause 
an oval shaped pupil which increases in its oval appearance over time. 
Slight to moderate iris tuck is probably only of cosmetic significance, but if 
severe it can be accompanied by pain, cause chronic inflammation leading to 
possible corneal complications, and/or cystoid macular edema. This may 
require removal of the IOL.21 
C) CORNEAL COMPLICATIONS 
1) CORNEAL EDEMA 
Corneal edema following IOL implantation, may result from a pre-exist-
ing corneal compromise, vitreo-corneal touch, inflammation, glaucoma, and/ 
or trauma. With development of newer styles of IOL's, better quality con-
trol, and improved surgical techniques, corneal complications have de-
creased markedly.22 However, corneal endothelial damage is still a problem 
with patients implanted with earlier IOL styles. 23 If the endothelial cell 
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damage is extensive, then bulluos keratopathy may result. This is 
characterized by general edema and clouding of the corneal stroma and 
epithelium with bleb formation. This condition is accompanied by pain and 
reduced visual acuity. 
Studies have shown that endothelial cell loss is more common with 
iris-supported lenses than either anterior or posterior chamber lenses with 
the posterior IOL'S appearing to cause less cell loss than other styles. 24,25 
2) IOL CORNEAL TOUCH (INTERMITTENT TOUCH SYNDROME) 
Repeated contact of an anterior chamber IOL with the cornea may cause 
ongoing loss of endothelial cells. Intermittent touch syndrome, as described 
by Drews,26 includes ciliary flush, localized corneal changes, and cystoid 
macular edema. Other factors such as rubbing the eye or working conditions 
may contribute to the pathogenesis of this syndrome. 
Early recognition is vital to the management and prevention of further 
corneal problems. With prompt elimination of the touch, the syndrome may 
be reversed. 
3) EPITHELIAL DOWN GROWTH 
Epithelial down growth is a result of poor surgical technique. It occurs 
when epithelium is introduced into a wound with uveal tissue, such as the 
iris. The epithelium then grows across the cornea and into the angle and may 
cause chronic inflammation coneal edema, and/or glaucoma. It is treated by 
removal of the epithelium. 
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4) KERATITIS and/or CORNEAL ULCERATION 
Eyes with previous corneal compromise, or bullous keratopathy are more 
susceptible to secondary corneal ulceration and keratitis than are healthy 
eyes. 
D) INFLAMMATORY COMPLICATIONS 
1) UVEITIS-GLAUCOMA-HYPHEMA (UGH) SYNDROME 
UGH syndrome, due to warped footplates of some anterior chamber 
lenses, produces a rocking motion of the lens causing a mechanical 
irritation at the iris root and adjacent structures of the angle. 27 This 
results in uveitis, hyphema, and glaucoma. The syndrome should subside if 
the implant is removed. This condition has recently decreased in incidence 
due to better quality control and refined lens design. However, UGH 
syndrome may still present itself with the use· of certain anterior chamber 
implants. 
It is important to note, that any one of the triad of symptoms occurring 
in UGH syndrome can be a single complication within itself. 
a) Uveitis 
Anterior uveitis usually occurs secondary to trauma or mechani-
cal irritation, while posterior uveitis is generally due to an autoimmune 
reaction associated with retinal lens material. Its onset is usually 2-4 
weeks post-operative. Both anterior and posterior uveitis may be treat-
ed with steroids. In addition, posterior uveitus frequently requires the 
removal of lens proteins. 
b) Glaucoma 
Glaucoma is a complication which needs to be identified early in the 
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disease process. Its cause may include one or more of the following: 
1) Inflammation of trabecular meshwork secondary to trauma 
2) Blockage by inflammatory debris and peripheral anterior synech-
iae occurring in anterior uveitis 
3) Blockage by vitreous prolapse 
4) Pigmentary block associated with iris atrophy 
5) Pupillary block - an obstruction between the pupil and iridec-
tomy causing a failure of communication of aqueous between the 
anterior and posterior chambers 
Treatment for glaucoma includes the use of therapeutical agents such as 
Timolol. If the cause of glaucoma is pupillary block, dilation may prove 
beneficial in allowing release of the obstruction which prevents normal 
aqueous flow. If not, surgery may be required. 
c) Hyphema 
Hyphema is a sanguineous or bloody exudate occurring in the anterior 
ch~mber of the eye. It is caused by leakage from wound vessels or iris 
vessels and has an onset of approximately 1-7 days post-operatively. A 
partial hyphema will usually absorb spontaneously without damaging the 
eye. A total hyphema, however, can cause a secondary glaucoma. Its 
treatment may include steroids and lOP control, and if severe, paracen-
tesis. 
2) INFECTIOUS ENDOPHTHALMITIS 
This inflammation of the internal tissue of the eye is a potentially 
devastating complication of any surgical procedure, including IOL 
implantation.28 Its symptoms include pain, chemosis, a rapidly developing 
hypopyon, and corneal decompensation. Its onset may be 2-3 days after sur-
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gery if bacterial or up to 3 months if caused by a fungal infection. The 
treatment and prognosis of infectious endophthalmitis depends on an early 
diagnosis aided by cultures of aspirated vitreous. 
3) SYMPATHETIC OPHTHALMITIS 
As with infectious endophthalmitis, sympathetic ophthalmitis may be a 
very serious complication of not only IOL implantation, but also with any 
surgical procedure or wound which may allow a foreign antigen to enter the 
eye. The disease begins by showing a chronic uveitis with cells, mutton fat 
Kp's, and an iritis occurring in the operated or wounded eye. The sympathiz-
ing eye soon follows. The initial uveitus must be treated with aggressive 
steroid use. If the inflammation of the exciting eye does not resolve, 
enucleation may be necessary to prevent involvment of the sympathizing 
eye. 
E) OPACIFICATION of the MEDIA 
1) PRECIPITATES on the POSTERIOR CORNEA or IOL 
These precipitates are mainly composed of pigment, inflammatory cells, 
fibrin, and blood breakdown products and seen on the posterior surface of 
the cornea or on the surfaces of the IOL. They present during the immediate 
post-operative period and usually clear spontaneously as the operated eye 
heals. However, if an inflammation becomes chronic or hemorrhage occurs, 
the precipitates may become dense enough to cause a decrease in vision.29 
2) POSTERIOR CAPSULAR OPACIFICATION 
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Posterior capsular opacification is a common complication of ECCE and 
is due to a migration of residual subcapsular epithelial cells (Eishnig 
bodies) to the posterior capsule where they lay down dense collagen fi-
bers. 30 The incidence of posterior capsular opacification seems to be 
higher in children and young adults. One study showed that up to SOo/o of 
adults develop an opaque secondary membrane within 3-Syears following 
ECCE.31 This opacification can decrease visual acuity and may be treated 
with surgical discission or by neodymium VAG capsulotomy.32 
F) MECHANICAL COMPLICATIONS CAUSED by the IOL 
Many of the complications due to mechanical factors of the IOL have 
been previously discussed. Therefore, only a brief summary of possible 
causes and associated effects will be considered below. 
1) Anterior Touch 
"Intermittent Touch" 
2) Posterior Touch 
Cause Possible Effects 
Vaulting or improper 1) Reduction of en do-
fit of ant. chamber IOL thelia! cells 
Contact of iris sup-
ported IOL with the 
motile iris 
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2) Edema, possibly 
assoc. with bullous 
keratopathy 
3) Glaucoma, if damage 
to angle 
1) Iris erosion or grat-
ing 
2) Breakdown of blood-
aqueous barrier 
3) Inflammation 
3) Erosion of anterior 
chamber angle 
4) Erosion of ciliary 
sulcus 
Excessive contact of 
an ant. chamber IOL 
with the ant. chamber 
angle 
Excessive contact of 
post. chamber IOL 
loops with the ciliary 
sulcus 
1) Peripheral anterior 
synechiae 
2) Endothelial cell loss 
3) Fibrous metaphasia 
of the endothelium 
1) Neovascular glau-
coma (rare) 
G) COMPLICATIONS of LENS IMPLANT POSITION 
Dislocation or decentration of IOL implants were a common problem 
with early IOL's. These complications have since decreased with the advent 
of modern IOL's and better size determining estimates. A chart depicting 
possible complications of various IOL types if dislocation or decentration 
were to occur is found below. 
1) Iris-Fixated IOL's 
2) Anterior Chamber IOL's 
3) Posterior Chamber IOL's 
a) Iris chafing and erosion 
b) Difficulty in visualizing fundus 
c) Decrease in vision 
a) Iris chafing 
b) Iris tuck 
c) Excessive pressure and erosion into 
the anterior chamber angle recess, 
possibly causing glaucoma 
d) May dislodge through iris defects 
already present 
a) Visual problems 
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1) SUNSET SYNDROME 
b) Difficulty in visualizing the fundus, 
especially peripheral fundus 
c) Hypersensitivity reaction due to 
leaking lens fiber proteins 
d) "Windshield Wiper Syndrome" 
The "sunset syndrome" refers to an inferior decentration or dislocation 
of the IOL so that the superior edge of the lens is visible within the pupil-
lary aperture. This usually occurs as a result of inferior capsule disinser-
tion and may cause a decrease in vision or monocular diplopia. 
2) WINDSHIELD WIPER SYNDROME 
The "windshield wiper syndrome" occurs when a posterior chamber IOL 
is poorly fit and/or fixated. In this condition the implant moves from side 
to side on head tilt and may cause variable vision or diplopia. 
3) INDICATIONS for REFERRAL 
Indications for referral for surgical treatment of significant lens de-
centration, subluxation, or complete dislocation include decreased vision, 
excessive uveal touch, persistent uveitis, or retinal injury. 
OPTOMETRIC EVALUATION of the PSEUDOPHAKIC PATIENT 
1) CASE HISTORY 
A complete case history needs to be taken on every patient. It is impor-
tant to know when the surgery was performed and if any medications are 
still being used. Many surgeons prescribe oral and/or topical steroids to 
control post-surgical inflammation and mydriatics to prevent synechiae. 
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Normally, these pseudophakic patients are followed 6-8 weeks post-opera-
tively by their surgeon, but more and more, Doctors of Optometry are re-
sponsible for their care. Therefore, depending on your relationship with the 
surgeon, one should know their protocol for drug use before any modification 
in drug therapy is carried out. Special consideration should be given to any 
symptoms elicited from the patient. 
2) VISUAL ACUITY 
As with all patients, visual acuity is an important finding. This is 
especially true for pseudophakic patients since it is probably the main 
reason an implantation was performed. Be aware that any preexisting con-
dition that had decreased acuity before the implant, other than lenticular, 
will still be present. 
After refraction, the typical pseudophake achieves 20/20 or 20/25 acu-
ty.33 There are many factors involved, but a lower acuity should signal the 
possibility of an organic problem. Pinhole acuity is helpful in determining 
if the decrease is refractive. Other causes would include corneal edema, 
anterior or posterior uveitis, retinal detachment, capsular opacification, 
CME, and inflammatory reactions of the conjuntiva. Any decrease in acuity 
should be explained. If capsular opacification is suspected, testing for 
contrast sensitivity is useful. Take acuity readings with standard exam 
room lighting. Increase the lighting to the maximum level and retake 
acuities. Patients with an opacification will report a drop in acuity. 
3) REFRACTION 
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The refraction itself is essentially just good optometric care and for 
the most part is carried out as you would with any patient in your office. 
There are a number of points to consider, however. One should stress to a 
patient that after surgery their presciption may change as the eye heals 
requiring several changes in their glasses until the eye stabilizes. 
Keratometry readings are important on every pseudophake. The readings 
reveal corneal topography and the mires may give an indication of corneal 
health. Distorted mires may indicate dry spots or keratitis and irregular 
mires can be caused by tight sutures. The readings should be compared pre 
and post-surgically. If the IOL was implanted recently there is often a sig-
nificant change, but as the wound heals they generally return to 
pre-operative levels. If there is a large change that is stable, one should 
refer back to the surgeon because they can often manipulate the sutures to 
lessen the problem. Minus cylinder will be induced 90 degrees away from 
the tight suture. 
Retinoscopy also provides some valuable information. The reflex should 
appear comparatively bright, undistorted, and will provide a good starting 
point. A reflex that is dull is usually due to capsular opacification or cor-
neal changes. ·Capsular opacification results in a large neutrality zone 
while corneal edema gives a reflex that is difficult to neutralize. Also, a 
refex with conflicting motions indicates a crossed cylinder component 
between normal corneal astigmatism and surgically induced astigmatism, 
possibly due to a tilt of the IOL. 
Binocular tests should be included in any exam. This is especially 
important in the unilateral lens implant patient. The two eyes probably 
have not been operating binocularly for some time due to the deprivation in 
one eye and binocular fusion may be limited. Therefore, the clinician should 
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test fusion, convergence, and stereopsis when applicable.34 The patient 
may need supportive visual training and/or prisms to obtain comfortable 
fusion. 
Any anisometropia needs to be carefully evaluated. Those with anise-
konia need special care. The clinician may need to change base curves, mag-
nification, lens thickness, or add prisms to correct the problem.35 
4) BIOMICROSCOPY 
The biomicroscope is an essential tool in assessing anterior chamber 
health, media clarity, and the implant itself. The cornea is the sight of the 
most frequent complications of IOL surgery. Therefore we must be alert for 
signs of edema such as Decemet's folds, subepithelial microcysts, corneal 
thickening, and corneal striae. Generally, all signs of edema should have 
subsided within 6-8 weeks after surgery. Edema after that point in time 
should be reported to the surgeon. 
A mild keratitis may be present and is usually the result of dry eyes or 
post-operative antibiotics. Tear supplements can be used in the case of dry 
eyes and in the case of antibiotics, the surgeon should be notified. Corneal 
staining should clear up significantly within one week after the initiation 
of artificial tears or discontinuation of the drugs. 
The cornea should also be checked for any precipitates. They may be an 
indication of an inflammatory reaction, such as uveitis. 
The wound area must be evaluated. Tight sutures can cause wrinkles in 
Decemet's membrane which will form a "V" pointing to the stiches.36 The 
refraction will frequently show corresponding astigmatism. Look for spon-
taneous fistula blebs which can be caused by leakage of the aqueous from 
the wound. This can be checked by instilling fluorescein and watching for a 
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green rivulet that flows from the wound. Fistula blebs are reason for an 
immediate referral to the surgeon. 
Screening for cells and flare is important. Traumatic uveitis is normally 
expected for about 6-8 weeks after the surgery. Remnants of the lens may 
be seen. Cortical remnants will appear whitish while capsular remnants 
will be clear.37 Pigment may be found, resulting from the surgery or by 
chafing from the implant. Excessive pigment or debris is an indication for 
gonioscopy which may also be used to check for peripheral anterior 
synechiae. 
The iris often suffers some trauma during surgery. If pigment epithe-
lium was stripped away by the procedure, there are often areas of iris 
transillumination. This pigment is often found clumped to the surface of a 
PCIOL. Long-term care involves monitoring any changes of the atrophy indi-
cating a constant chafing. 
With ACIOL's, check the peripheral iris for signs of iris tuck or anterior 
synechiae. Check the pupil for evidence of an iris prolapse, especially in 
ICCE procedures.38 With IFIOL's and ICIOL's, check the clips and sutures for 
any signs of erosion or iris thinning and iridodialysis.39 The pupil itself 
should react to light both directly and consensually. Normally ACIOL's and 
PCIOL's will have round or slightly elongated pupils. Synechiae or pupillary 
capture will distort the pupil's shape. With IFIOL's or ICIOL's, a square pupil 
may be the result due to the connecting sutures used. 
Check the position of the implant. Patient symptoms are a good indica-
tor if there is a problem. Reports of monocular diplopia or half fields of 
clear vision are associated with a decentered lens. Often the lens can be 
decentered slightly with minimal visual problems but it should be mon-
itored for changes over time. ACIOL's and PCIOL's should show no movement 
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when the eye is moved to different positions of gaze. Iris fixated lenses 
may shake when the eye is moved but the movement should be minimal and 
not result in diplopia or prolonged blur. This movement is known as pseudo-
phakodonesis. 
The implant should also be evaluated for clarity. Any precipitates such 
as pigment, inflammatory cells, etc. have to be noted. Make sure that there 
isn't any sign of perilenticular membrane growth. In ECCE procedures check 
the posterior capsule.40 Any debris deposition, inflammatory exudates, 
Elschnig pearls, and fibrotic or cell growth can decrease clarity. If vision 
is being effected, the patient should be referred back to the surgeon. 
5) FUNDUS EVALUATION 
With the addition of the implant, the view will be magnified. Adequate 
view of the peripheral fundus requires dilation, which must be done 
carefully. With modren ACIOL's and PCIOL's, the pupil may be safely dilated 
but with iris-fixated lenses, dilation by an Optometrist is not recommended. 
There is a significant chance for dislocation and if there is some 
vascularization around the sutures, hemorrhage may occur. 
Once dilated, the clinician should look for of posterior uveitis, CME, and 
retinal detachments.41 CME may be difficult to diagnose and can only be 
confirmed by fluorescein angiography. In cases where there is no apparent 
cause of decreased acuity, it is prudent to refer patients for this procedure. 
6) TONOMETRY 
Finally, any patient with an implant has to have pressures taken every 6 
months. Ocular inflammation, pigment dispersion, pupillary block, possible 
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steroid anti-inflammatory agents, and angle erosions are some of the 
causes of secondary glaucoma.42 Therefore, the patient has to be monitoed 
regularly. 
SUMMARY 
As Optometrists, it is not only important for us to be able to provide 
maximum visual functioning and acuity, but also to be knowledgable about 
the broad spectrum of visual care. 
With increasing use of Intraocular Lenses, Optometrists will be seeing 
more and more of these patients. Therefore, it is essential for O.D.'s to 
familiarize themselves with this type of surgery and to provide sound 
advice and quality follow up care for these patients. 
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